News Ticker

[ February 29, 2024 ] Rare Diseases in Canada: Expert Panel Shines Spotlight on the Impact of Sustained Research and Innovation Releases
[ February 28, 2024 ] Interview Availability: Patient Perspectives on National Pharmacare Issues Releases
[ February 28, 2024 ] State of Celiac Disease in Canada – Underdiagnosed, Unaffordable and Unsafe Food: Survey Releases
[ February 27, 2024 ] ALS Canada and Brain Canada invest in future leader of ALS research with 2023 Career Transition Award Releases
[ February 9, 2024 ] Collaborative Advocacy in Action Releases

AGRISSO™ (osimertinib) approved by Health Canada as treatment for patients with locally advanced or metastatic EGFR T790M mutation-positive non-small cell lung cancer

July 11, 2016 Media Digest

Copyright © 2024 | Research Canada